DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Meyer T, Roughton M, Yu D , et al.
A randomized phase II/III trial of three weekly cisplatin based transarterial chemoembolization (TACE) versus embolization (TAE) alone for hepatocellular cancer (HCC) [Abstract 4025].
J Clin Oncol 2010;
28 (suppl): 15s
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.